In this video, Professor John Hardy describes two key advances in Alzheimer’s and Parkinson’s disease. First, functionally related risk genes are clarifying the underlying biology. Second, genetics is improving our ability to predict who will develop the disease, which matters because treatment will likely need to begin before symptoms appear.
Early-onset forms appear to be driven by overproduction of amyloid or other damaging proteins. Late-onset forms, by contrast, seem to stem mainly from failure to clear these proteins.
Last reviewed on 16-09-2026.